Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933008 · ClinicalTrials.gov registry record · NA
Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT02933008 is a NA study that has completed, run by Emory University. The registered enrollment target is 420 participants.
The verdict
NCT02933008, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
Traumatic, debilitating anterior cruciate ligament (ACL) injuries occur at a 2 to 10-fold greater rate in female than male athletes. Consequently, there is a larger population of females that endure significant pain, functional limitations, and radiographic signs of knee osteoarthritis (OA) within 12 to 20 years following injury. To reduce the burden of OA, The National Public Health Agenda for Osteoarthritis recommends expanding and refining evidence-based prevention of ACL injury. Specialized training that targets modifiable risk factors shows statistical efficacy in high-risk athletes; however, clinically meaningful reduction of risk has not been achieved. A critical barrier that limits successful training outcomes is the requirement of qualified instructors to deliver personalized, intuitive, and accessible feedback to young athletes. Thus, a key gap in knowledge is how to efficiently deliver objective, effective feedback during training for injury prevention. The investigators long-term goal is to reduce ACL injuries and the subsequent sequela in young female athletes. The overall objective of this proposal is to implement and test innovative augmented neuromuscular training (aNMT) techniques to enhance sensorimotor learning and reduce biomechanical risk factors for ACL injury. The rationale that underlies this proposal is that, after completion, the investigators will be equipped to more effectively deliver biofeedback and decelerate the trend of increasing ACL injury rates in female athletes. This contribution will be significant for the reduction of the long-term sequel following ACL injury in young females.
Interventions
- OTHER Neuromuscular Training
- OTHER aNMT Biofeedback
- OTHER Sham Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2016-12 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933008
The ClinicalTrials.gov registry entry for NCT02933008 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Neuromuscular Training is the first listed.
NCT02933008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02933008 about?
NCT02933008 is a clinical study titled "Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality". Traumatic, debilitating anterior cruciate ligament (ACL) injuries occur at a 2 to 10-fold greater rate in female than male athletes. Consequently, there is a larger population of females that endure significant pain, functional limitations, and radiographic signs of knee osteoarthritis (OA) within 1...
What is the current status of trial NCT02933008?
This trial is currently completed. It is a NA study. The enrollment target is 420 participants. The study started on 2016-12. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT02933008?
The interventions under investigation include: Neuromuscular Training (OTHER), aNMT Biofeedback (OTHER), Sham Biofeedback (OTHER).
Who is sponsoring clinical trial NCT02933008?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.